UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.
The study, the most comprehensive analysis ever conducted of RNA molecules in human saliva, reveals that saliva contains many of the same disease-revealing molecules that are contained in blood. It was published online today by the peer-reviewed journal Clinical Chemistry and will be published in the journal’s January 2015 special print issue, “Molecular Diagnostics: A Revolution in Progress.”
“If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,” said Dr. David Wong, a senior author of the research and UCLA’s Felix and Mildred Yip Endowed Professor in Dentistry.
Wong said the test also holds promise for diagnosing Type 2 diabetes, gastric cancer and other diseases. “If you don’t look in saliva, you may miss important indicators of disease,” Wong said. “There seems to be treasure in saliva, which will surprise people.”
RNA, widely known as a cellular messenger that makes proteins and carries out DNA’s instructions to other parts of the cell, is now understood to perform sophisticated chemical reactions and is believed to perform an extraordinary number of other functions, at least some of which are unknown.
Wong’s research over the past decade has focused on identifying biomarkers in saliva. His laboratory discovered that some of the same RNA that is inside human cells are also present in saliva and can be used to detect diseases — a surprising finding, he said, because enzymes in saliva can degrade RNA, making the mouth “a hostile environment.”
The new research is a collaboration with Xinshu (Grace) Xiao, the paper’s other senior author and a UCLA associate professor of integrative biology and physiology in the UCLA College. Using state-of-the-science genomics and bioinformatics, the researchers analyzed 165 million genetic sequences.
Among the many forms of RNA are some unusual ones that live in the mouth and in cells. For example, it wasn’t known until very recently that RNA comes in a circular form; the linear form has long been known. But the UCLA scientists identified more than 400 circular RNAs in human saliva — the first discovery of circular RNA in saliva or any body fluid — including 327 forms that were previously unknown.
Circular RNA’s function in saliva is not entirely understood, although it does serve as a sponge for tiny RNA molecules called microRNAs, which bind to it.
“Circular RNAs in saliva may be protecting other RNAs,” said Xiao, who also is a member of UCLA’s Molecular Biology Institute. It’s likely, she said, that circular RNAs in saliva protect microRNAs from being degraded.
MicroRNAs, which once seemed to be little more than molecular noise, play important roles in many cell types, and have been implicated in cancers and other diseases, Xiao said. One microRNA can regulate hundreds of genes, she said.
The scientists compared microRNA levels in saliva to those in the blood and other body fluids, and found the levels of microRNA in blood and in saliva are very similar — indicating that a saliva sample would be a good measure of microRNAs in the body.
They also found that saliva contains another class of small RNAs, called piwi-interacting RNAs, or piRNAs, which are produced by stem cells, skin cells and germ cells. There are very few piRNAs in blood and most other body fluids, but Xiao’s analysis showed that piRNA are abundant in saliva. Although their function is not yet known, Xiao said they may protect the body from viral infection.
While most RNA molecules translate genetic code from DNA to make proteins, there is also a class called non-coding RNAs that does not.
“Saliva carries with it non-coding RNAs, microRNAs, piRNAs and circRNAs that are biomarkers for disease and health monitoring,” said Wong, who also is associate dean of research at the UCLA School of Dentistry. “Had we not done this collaboration, we would never know that non-coding RNAs, microRNAs, piRNAs and circRNAs exist in saliva.”
Their overriding conclusion is that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists might be able to take saliva samples to analyze for a variety of diseases. And, Wong says, the research could lead to a new category of self-diagnostic devices. “This could indicate that wearable gear that informs you whether you have a disease — even before you have any symptoms — is almost here,” he said.
The Latest on: Molecular diagnostics
via Google News
The Latest on: Molecular diagnostics
- Mesa Biotech Receives Emergency Use Authorization from FDA for a 30 Minute Point of Care Molecular COVID-19 Teston March 24, 2020 at 4:00 am
/PRNewswire/ -- Today, Mesa Biotech announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for its Accula™ ...
- A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal canceron March 24, 2020 at 3:16 am
As such, differences in molecular tumor traits between study populations probably cannot explain the ... with a Reflotron bench-top analyzer (Roche Diagnostics) until 2004, and from 2004 with a ...
- II-VI Incorporated Ramps Manufacturing Capacity of Components and Subassemblies for Molecular Diagnostic Testing Systemson March 23, 2020 at 5:34 pm
PITTSBURGH, March 23, 2020 -- II-VI Incorporated (Nasdaq: IIVI), a leading provider of lasers, optics, thermoelectrics, and subassemblies for the life sciences market, today.
- Molecular diagnostics is the future of cancer care — if we make it user friendlyon March 18, 2020 at 11:31 am
The global molecular diagnostics market for cancer care was valued at $1.6 billion last year, up more than 10 percent from 2018. That’s just a fraction of the entire molecular diagnostics field, but ...
- Earnings Preview: HTG Molecular Diagnostics, Inc. (HTGM) Q4 Earnings Expected to Declineon March 18, 2020 at 10:26 am
The market expects HTG Molecular Diagnostics, Inc. (HTGM) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2019. This ...
- Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assayon March 17, 2020 at 5:40 pm
Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has received Emergency Use Authorization (EUA) ...
- Molecular Diagnostics Market to Reach USD 14.94 Billion By 2027 | Reports and Dataon March 17, 2020 at 8:10 am
According to the current analysis of Reports and Data, the Global Molecular Diagnostics Market was valued at USD 8.28 Billion in 2019 and is expected to reach USD 14.94 Billion by the year 2027, at a ...
- Oncology Molecular Diagnostics Market 2020 Global Forecast To 2020on March 17, 2020 at 3:43 am
Oncology Molecular Diagnostics Market To Expand Rapidly at Notable CAGR as the Increasing demand for Automated and Advanced Diagnostic, Rising Preference Towards Precision Medicine are the factors ...
- POC Molecular Diagnostics Market to 2027 Report Reviews Global Analysis and Forecasts - Market Research Engineon March 16, 2020 at 1:39 pm
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous ...
- Worldwide Molecular Diagnostics Market - Size, Share & Trends Analysis Report (2020 to 2027) - ResearchAndMarkets.comon March 16, 2020 at 9:38 am
DUBLIN--(BUSINESS WIRE)--The "Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), by Test Location, by Technology, by Application, by Region, and ...
via Bing News